169 related articles for article (PubMed ID: 25890496)
1. The role of Hippo signaling in tooth development.
Li CH; Li CZ
J Formos Med Assoc; 2016 May; 115(5):295-7. PubMed ID: 25890496
[No Abstract] [Full Text] [Related]
2. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
3. Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells.
Melfi S; Colciago A; Giannotti G; Bonalume V; Caffino L; Fumagalli F; Magnaghi V
Cell Death Dis; 2015 Oct; 6(10):e1915. PubMed ID: 26469964
[No Abstract] [Full Text] [Related]
4. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction. Neither straight nor narrow.
Peifer M
Nature; 1999 Jul; 400(6741):213-5. PubMed ID: 10421354
[No Abstract] [Full Text] [Related]
6. Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway.
Nishio M; Maehama T; Goto H; Nakatani K; Kato W; Omori H; Miyachi Y; Togashi H; Shimono Y; Suzuki A
Genes Cells; 2017 Jan; 22(1):6-31. PubMed ID: 28078823
[TBL] [Abstract][Full Text] [Related]
7. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
8. Hippo signaling maintains the phenotype of pancreatic acinar cells.
Sosa-Pineda B
Gastroenterology; 2013 Jun; 144(7):1345-8. PubMed ID: 23623964
[No Abstract] [Full Text] [Related]
9. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
Park YY; Sohn BH; Johnson RL; Kang MH; Kim SB; Shim JJ; Mangala LS; Kim JH; Yoo JE; Rodriguez-Aguayo C; Pradeep S; Hwang JE; Jang HJ; Lee HS; Rupaimoole R; Lopez-Berestein G; Jeong W; Park IS; Park YN; Sood AK; Mills GB; Lee JS
Hepatology; 2016 Jan; 63(1):159-72. PubMed ID: 26389641
[TBL] [Abstract][Full Text] [Related]
10. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer].
Guo LW; Shao GL
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286
[TBL] [Abstract][Full Text] [Related]
11. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
14. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
15. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
16. Regulators of mammalian Hippo pathway in cancer.
Liu AM; Wong KF; Jiang X; Qiao Y; Luk JM
Biochim Biophys Acta; 2012 Dec; 1826(2):357-64. PubMed ID: 22683405
[TBL] [Abstract][Full Text] [Related]
17. [Hippo-YAP signaling pathway in the liver: more than a size gatekeeper!].
Gilgenkrantz H
Med Sci (Paris); 2011 May; 27(5):479-81. PubMed ID: 21609667
[No Abstract] [Full Text] [Related]
18. [The world according to YAP: a continuous cross-talk between Wnt and Hippo pathways].
Gilgenkrantz H
Med Sci (Paris); 2013 Oct; 29(10):868-74. PubMed ID: 24148125
[TBL] [Abstract][Full Text] [Related]
19. The Hippo pathway in normal development and cancer.
Maugeri-Saccà M; De Maria R
Pharmacol Ther; 2018 Jun; 186():60-72. PubMed ID: 29305295
[TBL] [Abstract][Full Text] [Related]
20. YAP and TAZ, the conductors that orchestrate eye development, homeostasis, and disease.
Zhu JY; Lin S; Ye J
J Cell Physiol; 2018 Jan; 234(1):246-258. PubMed ID: 30094836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
